Company Overview and News

 
India banks to plan resolving $19 billion power sector debt on Thursday

2018-09-19 livemint
Mumbai/New Delhi: Lenders to India’s power industry are scheduled to meet on Thursday to discuss ways to resolve ₹1.4 trillion ($19.2 billion) of stressed assets that’s hobbling the sector, people with knowledge of the matter said.
PFC PWQFY 532627 JPPOWER 532955 RECLTD 532810 SBAZ

 
Jaiprakash Power Ventures Limited - AGM/Book Closure

2018-09-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532627 JPPOWER

 
Union Bank of India expects Rs 2,000 crore recovery from resolution of stressed power projects

2018-09-05 moneycontrol
State-owned Union Bank of India hopes to recover Rs 2,000 crore from the resolution of three stressed thermal power units as there has been interest from other operators in these projects.
UBNC 532627 JPPOWER

 
Check out the top 10 stocks which moved the most last week

2018-09-02 moneycontrol
Equities did not have the best of their starts to a new series, with the Nifty ending the first day of September series below 11,700-mark. However, bulls did manage to battle it out well with the bears as the market was off its low points.
500219 ABBOTINDIA 570004 RELEY RIFS 539254 RELFF 532627 JISLJALEQS TCHQY 532778 532755 TECHM 500390 RELINFRA JISLDVREQS RIFA JPPOWER 500488 LITL ADANITRANS

 
JP Power Ventures: Board to settle lenders

2018-08-31 thehindubusinessline
The board of Jaiprakash Power Ventures on Friday approved a proposal to alter its MoA to increase its authorised share capital to ₹20,050 crore from ₹10,050 crore, mainly to convert the debt of lenders into equity (by cumulative compulsory convertible preference shares up to ₹4,000 crore). The board also approved an issue of 35.20 crore shares on preferential basis to unsecured creditors. The lenders include ICICI Bank, IDBI Bank, PNB, Central Bank, SBI, UBI and Canara Bank.
ICICIBANK 500116 532483 532174 IBN IDBI 532627 JPPOWER CANBK CNRYY

 
JPVL board approves hike in authorised capital, conversion of Rs 4,000 crore debt into equity

2018-08-31 moneycontrol
Jaiprakash Power Ventures today said its board has approved the proposal to alter its memorandum of association to increase authorised share capital of the company to Rs 20,050 crore from Rs 10,050 crore, mainly to convert debt of lender into equity.
IOB UDBKL IDBI UBLS 532418 532388 SYNDIBANK 532121 532461 532483 UBLA 532480 SBAZ UBNC 500116 IBN 532627 ALBK CNRYY 532179 ICICIBANK 532276 PNJZY CRPKY 532174 JPPOWER PNB CORPBANK CANBK DENABANK ANDHRABANK

 
Jaiprakash Power Ventures Limited - Outcome of Board Meeting

2018-08-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532627 JPPOWER

 
Deals Buzz: NCLT approves Vodafone-Idea merger

2018-08-31 livemint
The National Company Law Tribunal gave its nod to the merger of Vodafone and Idea, which will create India’s largest telecom company, displacing Bharti Airtel from the top spot, The Economic Times reported. The new entity will have 440 million subscribers, a 34.7% revenue market share (RMS), revenue of more than Rs 60,000 crore and combined debt of over Rs 1.15 lakh crore. Mint reported on July 11 that telecom minister Manoj Sinha said the merger is approved with only formalities remaining.
532454 TATAPOWER 532627 TPCL JPPOWER 500400 BHRQY BHARTIARTL JSWENERGY 533148

 
JSW submits revised bid worth ₹6,200 crore for Prayagraj Power

2018-08-30 livemint
Mumbai: JSW Energy has submitted a revised bid of ₹6,200 crore for the debt-laden Prayagraj Power Generation Co. Ltd, outbidding Resurgent Power Ventures Pte Ltd by ₹200 crore, two people close to the development said on condition of anonymity.
TATAPOWER 532627 TPCL JPPOWER 500400 JSWENERGY SBAZ 533148

 
Tata Power JV buys 75% stake in Prayagraj for Rs 6,000 crore

2018-08-30 freepressjournal.in
New Delhi : Resurgent Power, a joint venture of Tata Power Company and ICICI Ventures, has acquired a 75 per cent stake in Prayagraj Power Generation for Rs 6,000 crore, the company said on Wednesday.
532532 ICICIBANK JIPKY 532174 IBN TATAPOWER 532627 TPCL JPPOWER JPASSOCIAT 500400 SBAZ

4
An evening walk down Dalal Street | Nifty jittery ahead of FO expiry, Sensex sheds 38,750; midcaps gain

2018-08-29 moneycontrol
A sharp selloff in the last hour of trade weighed on equity benchmarks on Wednesday, with the Nifty giving up 11,700-mark. Weakness among giant index names such as Reliance Industries, HDFC Bank, and Infosys, among others, dragged the market lower as well.
500325 500228 RELIANCE 532832 533278 CADILAHC 532321 RIGD HDFCBANK BJJQY CLNDY RLNIY 500034 SBAZ FISI 532627 FIISO FIISP JSWSTEEL CDLYY BRK.A BAJFINANCE HDB 500180 JPPOWER COALINDIA IBREALEST

3
JP Power Ventures up 11% as board to consider loan conversion of Rs 4000cr

2018-08-29 moneycontrol
Shares of Jaiprakash Power Ventures added more than 11 percent intraday Wednesday as company to consider loan conversion into preference shares.
BRK.A FISI 532627 JPPOWER FIISO FIISP

 
RBI deadline over, 20 new NPA accounts to go to NCLT

2018-08-28 livemint
Mumbai: As the deadline set by the Reserve Bank of India (RBI) for resolution of stressed assets ended Monday, lenders have decided to refer 20 of at least 32 NPA accounts to bankruptcy courts, according to two bankers aware of the matter. For the remaining 12 NPA accounts, lenders will either restructure the debt or initiate sale proceedings, the bankers said on condition of anonymity.
UBNC 533096 532627 JPPOWER ADANIPOWER SBAZ 532775 GTLINFRA

 
Jaiprakash Power logs Rs 4 cr profit

2018-08-06 freepressjournal.in
NEW DELHI: Jaypee Group subsidiary Jaiprakash Power Ventures (JPVL) on Sunday announced a turnaround in performance in the first quarter ending in June to record a net profit of Rs 4 crore on standalone basis.
532627 JPPOWER

 
Jaiprakash Power Ventures Limited - Financial Result Updates

2018-08-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
532627 JPPOWER

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...